title: Dose-ranging study of the luteinizing hormone-releasing hormone receptor antagonist cetrorelix pamoate in the treatment of patients with symptomatic benign prostatic hyperplasia.
authors.affiliation: Department of Urology, Academic Hospital Nijmegen, Nijmegen, The Netherlands. f.debruyne@uroweb.org
authors.forename: Frans
authors.initials: F
authors.lastname: Debruyne
authors.forename: Mitko
authors.initials: M
authors.lastname: Tzvetkov
authors.forename: Silvio
authors.initials: S
authors.lastname: Altarac
authors.forename: Petrisor A
authors.initials: PA
authors.lastname: Geavlete